Hudson Technologies, Inc. (HDSN)

Inozyme Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	18.17	24.39	52.25	103.8	32.26	-5.21
Depreciation & Amortization	6.51	6.39	5.78	5.98	6.18	6.1
Other Amortization	0.23	0.23	0.73	1.09	1.13	1.13
Asset Writedown & Restructuring Costs	-	0.44	2.12	-	-	-
Stock-Based Compensation	0.63	0.84	2.31	0.92	0.51	0.66
Provision & Write-off of Bad Debts	-0.93	-0.77	0.66	0.47	0.04	0.88
Other Operating Activities	1.71	2.55	5.48	5.05	-4.94	-4.77
Change in Accounts Receivable	-7.26	12.31	-4.96	-7.12	-4.46	-2.63
Change in Inventory	44.49	60.25	-6.81	-53.07	-46.88	18.71
Change in Accounts Payable	9.56	-12.73	9.46	4.53	16.38	-0.7
Change in Income Taxes	-0.54	-0.85	-5.28	-0.63	0.67	-0.3
Change in Other Net Operating Assets	-1.01	-1.24	-3.18	1.8	-2.12	-2.18
Operating Cash Flow	71.55	91.81	58.55	62.82	-1.23	11.69
Operating Cash Flow Growth	-8.43%	56.82%	-6.79%	-	-	-65.44%
Capital Expenditures	-5.09	-5.3	-3.58	-3.66	-1.92	-1.47
Cash Acquisitions	-	-20.67	-	-	-	-
Other Investing Activities	-	-	-	-	-	1
Investing Cash Flow	-5.09	-25.97	-3.58	-3.66	-1.92	-0.47
Short-Term Debt Issued	-	-	-	-	13	-
Long-Term Debt Issued	-	-	-	100	-	2.48
Total Debt Issued	-	-	-	100	13	2.48
Short-Term Debt Repaid	-	-	-	-	-	-12
Long-Term Debt Repaid	-	-	-47.16	-148.05	-5.25	-3.01
Total Debt Repaid	-	-	-47.16	-148.05	-5.25	-15.01
Net Debt Issued (Repaid)	-	-	-47.16	-48.05	7.75	-12.53
Issuance of Common Stock	-	-	0.04	0.18	0.2	0.06
Repurchase of Common Stock	-12.68	-8.15	-	-	-	-
Other Financing Activities	-0	-0.01	-0.69	-9.48	-2.66	-
Financing Cash Flow	-12.69	-8.15	-47.82	-57.35	5.29	-12.47
Net Cash Flow	53.77	57.69	7.15	1.8	2.14	-1.25
Free Cash Flow	66.46	86.51	54.97	59.16	-3.15	10.22
Free Cash Flow Growth	-9.35%	57.39%	-7.08%	-	-	-68.86%
Free Cash Flow Margin	29.57%	36.48%	19.02%	18.19%	-1.63%	6.92%
Free Cash Flow Per Share	1.44	1.84	1.16	1.26	-0.07	0.24
Cash Interest Paid	0.69	0.69	4.48	11.7	10.16	11.38
Cash Income Tax Paid	8.99	8.99	18.54	15.46	0.13	-0.05
Levered Free Cash Flow	64.8	77.02	37.81	26.38	-13.38	12.42
Unlevered Free Cash Flow	64.57	76.8	42.3	34.25	-7.39	19
Change in Net Working Capital	-49.92	-56.37	11.07	51.19	38.6	-10.03

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q